Related Experiment Video
Updated: May 7, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Infant respiratory syncytial virus infection disrupts β2 adrenergic airway relaxation via epithelial CXCL11
Caiqi Zhao1, Alice E Taliento1, Elise M Belkin1
1Division of Newborn Medicine, Department of Pediatrics, Massachusetts General Hospital, Boston, MA, United States.
Insights
Respiratory syncytial virus (RSV) bronchiolitis in infants impairs airway smooth muscle cell relaxation by upregulating CXCL11, which targets the ACKR3 receptor. This pathway desensitizes beta-2 adrenergic receptors (β2AR), suggesting new therapeutic targets for severe RSV.
Area of Science:
- Respiratory viral infections
- Airway smooth muscle physiology
- Molecular signaling pathways
Background:
- Infant respiratory syncytial virus (RSV) bronchiolitis is characterized by airflow obstruction unresponsive to beta-2 adrenergic receptor (β2AR) agonists.
- The underlying mechanisms of this unresponsiveness are poorly understood, and effective treatments are lacking.
Purpose of the Study:
- To investigate the impact of infant RSV infection on β2AR signaling in airway smooth muscle cells (ASMCs).
- To elucidate the molecular mechanisms by which RSV affects β2AR function in ASMCs.
Main Methods:
- Utilized complementary human and mouse models, including infant precision-cut lung slices (PCLSs), neonatal epithelial air-liquid interface (ALI) cultures, and mouse pups.
- Assessed β2AR-mediated ASMC relaxation and performed cytokine profiling, bulk RNA sequencing, and β2AR expression/function assays.
- Validated findings using nasopharyngeal aspirates (NPA) from infants with severe bronchiolitis.
Main Results:
- RSV infection of infant bronchial epithelium induced cytokine secretion, impairing β2AR-mediated ASMC relaxation.
- CXCL11 was identified as the key upregulated cytokine, signaling through ACKR3 to promote β2AR phosphorylation, internalization, and degradation.
- Blockade of CXCL11 or ACKR3 restored β2AR responsiveness in RSV-infected infant lung tissues and tissues exposed to NPA from severe bronchiolitis patients.
Conclusions:
- Infant RSV bronchiolitis utilizes the CXCL11-ACKR3 signaling pathway to desensitize β2AR in ASMCs.
- Targeting the CXCL11-ACKR3 pathway presents a potential therapeutic strategy to enhance β2AR agonist efficacy in severe RSV bronchiolitis.
Rationale:
Airflow obstruction unresponsive to β2 adrenergic receptor (β2AR) agonists is a key feature of infant respiratory syncytial virus (RSV) bronchiolitis. The underlying mechanisms remain poorly understood, and effective treatment is lacking.
Objectives:
To investigate whether and how infant RSV infection affects β2AR signaling in airway smooth muscle cells (ASMCs).
Methods:
We established complementary human and mouse models of RSV infection using infant (0-18 months) precision-cut lung slices (PCLSs), neonatal epithelial air-liquid interface (ALI) culture, and mouse pups to assess β2AR-mediated ASMC relaxation. Cytokine profiling was performed using conditioned medium (CM) from RSV-infected neonatal ALI culture. Infant ASMCs treated with CM were subjected to bulk RNA sequencing and β2AR expression and function assays. Findings were validated with nasopharyngeal aspirates (NPAs) from infants with severe bronchiolitis.
Measurements And Main Results:
RSV selectively targeted infant bronchial epithelium, inducing cytokine secretion that impaired β2AR-mediated ASMC relaxation. CXCL11 was the most upregulated epithelial cytokine and signaled to infant ASMCs through ACKR3, a β-arrestin-poised receptor that interacted with β2AR to promote its phosphorylation, internalization, and degradation. Using mouse strains with genetic variation in Cxcl11, along with ACKR3 blockade and CXCL11 rescue assays, we demonstrated that CXCL11-ACKR3 signaling was both necessary and sufficient for β2AR dysfunction. Moreover, blockade of CXCL11 or ACKR3 restored β2AR responsiveness in infant PCLSs exposed to RSV or NPA from severe RSV bronchiolitis.
Conclusions:
Infant RSV bronchiolitis exploits CXCL11-ACKR3 signaling to desensitize β2AR in ASMCs. Targeting this pathway may improve β2AR agonist efficacy in severe RSV bronchiolitis.
More Related Videos
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
08:42Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
Published on: May 26, 2023
Related Concept Videos
Pulmonary Cycle: Exhalation
Breathing
Asthma I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...